Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01905826Recruiting

Natural History Study of GATA2 Deficiency and Related Disorders

Role: collaborator

NCT03922893Recruiting

Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer

Role: collaborator

NCT03738098Not ApplicableCompleted

NYCKidSeq: Incorporating Genomics Into Clinical Care of Diverse NYC Children

Role: collaborator

NCT02574390Completed

Answer ALS: Individualized Initiative for ALS Discovery

Role: collaborator

NCT02725684Completed

Using Genomic Analysis to Guide Individual Treatment in Glioblastoma

Role: collaborator

All 5 trials loaded